<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Johnson & Johnson Health Care Systems Inc. on April 27, 2026, for SURGIFLO Hemostatic Matrix Kit with Thrombi, with a ceiling value of $1,369.86 and an ultimate completion date of May 11, 2026.</p>
<p>Place of performance is Raritan, NJ. The order is firm fixed price with no set-aside.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a delivery order to Johnson & Johnson Health Care Systems Inc. on April 27, 2026, with a ceiling value of $4,325.88 for SURGIFLO Hemostatic Matrix Kit with Thrombi.</p>
<p>Place of performance is Raritan, NJ. The order is firm fixed price and carries an ultimate completion date of May 11, 2026.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a delivery order to Johnson & Johnson Health Care Systems Inc. on April 24, 2026, with a ceiling value of $4,109.58 for SURGIFLO Hemostatic Matrix Kit with thrombi.</p>
<p>Place of performance is Raritan, NJ. The order carries an ultimate completion date of May 8, 2026, and is priced on a firm fixed price basis. No set-aside was used for this award.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a delivery order to Johnson & Johnson Health Care Systems Inc. on April 8, 2026, for Surgiflo Hemostatic Matrix Kit with thrombi, with a ceiling value of $1,369.86 and an ultimate completion date of April 22, 2026.</p>
<p>This is a firm fixed-price delivery order with no set-aside. Place of performance is Raritan, NJ.</p>
<p>The Defense Logistics Agency Medical Supply Chain issued a $1,317.17 delivery order to Johnson & Johnson Health Care Systems Inc. on February 5, 2026, for Surgiflo Hemostatic Matrix Kit with Thrombi. Place of performance is Raritan, NJ. Ultimate completion date is February 20, 2026. The order is priced on a firm fixed price basis with no set-aside.</p>
<p>The Department of Defense Medical Supply Chain issued a $5,479.44 firm fixed price delivery order to Johnson & Johnson Health Care Systems Inc. on March 10, 2026, for SURGIFLO Hemostatic Matrix Kit with Thrombi, with ultimate completion on March 24, 2026.</p>
<p>Place of performance is Raritan, NJ. The order carries no set-aside.</p>
<p>The Defense Logistics Agency's Medical Supply Chain issued a $1,369.86 delivery order to Johnson & Johnson Health Care Systems Inc. on March 9, 2026, for Surgiflo Hemostatic Matrix Kit with Thrombi. The order is firm fixed price with an ultimate completion date of March 23, 2026. Place of performance is Raritan, NJ. No set-aside was used.</p>
The Defense Logistics Agency Troop Support Medical, on behalf of the Medical Supply Chain, issued a delivery order to Johnson & Johnson Health Care Systems Inc. on February 20, 2026, with a ceiling value of $8,219.16 for SURGIFLO Hemostatic Matrix Kit with Thrombi, a surgical hemostatic product. The order is issued under Johnson & Johnson Health Care Systems Inc.'s single-award Indefinite Delivery Contract with DLA Troop Support Medical (August 2024 to July 2029), which covers a...
The Defense Logistics Agency (DLA) Troop Support Medical issued a $13,698.60 delivery order to Johnson & Johnson Health Care Systems Inc. on March 11, 2026, for SURGIFLO Hemostatic Matrix Kit with Thrombi, with final completion scheduled for March 25, 2026.
The order is issued under a single-award Indefinite Delivery Contract with DLA Troop Support Medical running through July 2029. Place of performance is Raritan, NJ. The order is priced firm fixed price with no set-aside applied.
The Defense Logistics Agency's Medical Supply Chain issued a delivery order to Johnson & Johnson Health Care Systems Inc. on March 9, 2026, for SURGIFLO Hemostatic Matrix Kits with a ceiling value of $1,369.86. The order is a firm fixed-price call against Johnson & Johnson Health Care Systems Inc.'s $86.1 million single-award Indefinite Delivery Contract with DLA Troop Support Medical (August 2024 through July 2029), which covers DePuy Synthes joint procedural packages and related...